Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.
Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen MD, Rivet J, Moins-Teisserenc H, Ta VA, Ram-Wolff C, Bouaziz JD, Mahevas T, Bagot M, Mourah S, Louveau B, Sicre de Fontbrune F, Peffault de Latour R, de Masson A, Battesti G. Cohen E, et al. Among authors: bozonnat a. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e32-e34. doi: 10.1111/jdv.19408. Epub 2023 Aug 23. J Eur Acad Dermatol Venereol. 2024. PMID: 37561935 No abstract available.
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.
Bozonnat A, Assan F, LeGoff J, Bourrat E, Bachelez H. Bozonnat A, et al. J Clin Immunol. 2021 Oct;41(7):1511-1514. doi: 10.1007/s10875-021-01076-6. Epub 2021 Jun 26. J Clin Immunol. 2021. PMID: 34176064 Free PMC article. No abstract available.
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.
Bozonnat A, Beylot-Barry M, Dereure O, D'Incan M, Quereux G, Guenova E, Perier-Muzet M, Dalle S, Grange F, Viguier MA, Ram-Wolff C, Feldmeyer L, Beltraminelli H, Bonnet N, Amatore F, Maubec E, Franck N, Machet L, Chasset F, Brunet-Possenti F, Bouaziz JD, Battistella M, Donzel M, Pham-Ledard A, Bejar C, Moins-Teisserenc H, Mourah S, Saiag P, Hainaut E, Michel C, Bens G, Adamski H, Aubin F, Boulinguez S, Joly P, Tedbirt B, Templier I, Troin L, Montaudié H, Ingen-Housz-Oro S, Faiz S, Mortier L, Dobos G, Bagot M, Resche-Rigon M, Montlahuc C, Serret-Larmande A, de Masson A; Cutaneous Lymphomas French Study Group. Bozonnat A, et al. EClinicalMedicine. 2024 Dec 6;79:102979. doi: 10.1016/j.eclinm.2024.102979. eCollection 2025 Jan. EClinicalMedicine. 2024. PMID: 39720605 Free PMC article.
Response to Campbell et al.'s comments on our study "Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study".
Bozonnat A, Serret-Larmande A, Beylot-Barry M, Bagot M, de Masson A; Cutaneous Lymphomas French Study Group. Bozonnat A, et al. EClinicalMedicine. 2024 Oct 24;77:102895. doi: 10.1016/j.eclinm.2024.102895. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39513187 Free PMC article. No abstract available.
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.
Bozonnat A, Beylot-Barry M, Dereure O, D'Incan M, Quereux G, Guenova E, Perier-Muzet M, Dalle S, Grange F, Viguier MA, Ram-Wolff C, Feldmeyer L, Beltraminelli H, Bonnet N, Amatore F, Maubec E, Franck N, Machet L, Chasset F, Brunet-Possenti F, Bouaziz JD, Battistella M, Donzel M, Pham-Ledard A, Bejar C, Moins-Teisserenc H, Mourah S, Saiag P, Hainaut E, Michel C, Bens G, Adamski H, Aubin F, Boulinguez S, Joly P, Tedbirt B, Templier I, Troin L, Montaudié H, Ingen-Housz-Oro S, Faiz S, Mortier L, Dobos G, Bagot M, Resche-Rigon M, Montlahuc C, Serret-Larmande A, de Masson A; Cutaneous Lymphomas French Study Group. Bozonnat A, et al. EClinicalMedicine. 2024 Jun 21;73:102679. doi: 10.1016/j.eclinm.2024.102679. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 39007062 Free PMC article.
CD39 is expressed by a wide range of cutaneous T-cell lymphomas.
Battesti G, Thonnart N, Bozonnat A, Ram-Wolff C, de Masson A, Bensussan A, Bagot M, Marie-Cardine A, Battistella M. Battesti G, et al. Among authors: bozonnat a. Skin Health Dis. 2024 Jan 10;4(2):e334. doi: 10.1002/ski2.334. eCollection 2024 Apr. Skin Health Dis. 2024. PMID: 38577051 Free PMC article.
Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome.
Ranjbaryan M, Calvani J, Louveau B, Cuccuini W, Battesti G, Bozonnat A, Moins-Teisserenc H, Michonneau D, Bagot M, Ram-Wolff C, Dobos G, Mourah S, Battistella M, de Masson A. Ranjbaryan M, et al. Among authors: bozonnat a. Eur J Dermatol. 2023 Aug 1;33(4):439-440. doi: 10.1684/ejd.2023.4522. Eur J Dermatol. 2023. PMID: 37823502 No abstract available.
11 results